ArkeaBio vs Arya.ag

Side-by-side comparison of AI visibility scores, market position, and capabilities

ArkeaBio

EmergingAgTech

Livestock Biotech (Methane Reduction)

$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.

About

ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.

Full profile

Arya.ag

ChallengerAgTech

Post-Harvest Finance & Commodity Marketplace (India)

Raised ~$80M (₹670 crore) in Q1 2026 — one of India's largest agritech rounds. Connects smallholder farmers to institutional commodity buyers with warehouse-backed financing.

About

Arya.ag is an Indian agritech company that connects smallholder farmers to institutional commodity buyers while providing warehouse-backed post-harvest financing — addressing two of the most critical failures in Indian agricultural markets simultaneously. The company raised approximately $80 million (₹670 crore) in Q1 2026, one of India's largest agritech funding rounds, reflecting institutional confidence in B2B agritech profitability at scale.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.